Bob Oliver

Bob Oliver has extensive work experience in the pharmaceutical and biotech industries. Bob has served as an Independent Director for Exelixis and PsyBio Therapeutics Corp. Bob has also worked as an Executive Advisor at CELLIX BIO Sciences, Inc. and as a member of the Board of Directors for Neurotez, Inc. and Hyalo Technologies.

In addition, Bob Oliver has held roles at Medison Pharma Ltd. as an Independent Director and Executive Advisor, at V ClinBio as Interim CEO, at Otsuka Canada Pharmaceutical Inc. as Board Chairman, and at Otsuka Pharmaceutical Companies (U.S.) in various leadership positions including Chief Executive Officer, President & COO, and Senior Vice President of Sales & Marketing.

Prior to these roles, Bob Oliver gained valuable experience at Pfizer, where they served as Senior Vice President of Commercial Operations, Vice President & Global Business Manager for Oncology, and Vice President of Vaccines Sales. Bob played a crucial role in the global launch of an oncology asset and maintained national responsibility for vaccine sales.

Overall, Bob Oliver has demonstrated their expertise and leadership in the pharmaceutical and biotech sectors through their various roles and responsibilities.

Bob Oliver holds a Bachelor's degree in Community Development from Rutgers University. Bob also obtained a Master of Business Administration (MBA) from Saint Joseph's University. Additionally, they have a certification as a Six Sigma Green Belt from Six Sigma.